Table 5 Meta-analysis of the efficacy of colchicine on need for artificial ventilation in patients with COVID-19
From: The role of colchicine in the management of COVID-19: a Meta-analysis
Study | Type of study | Relative Risk | 95% CI | P-value |
|---|---|---|---|---|
Deftereos et al. 2020 | RCT | 0.18 | 0.02–1.61 | 0.088555 |
Tardif et al. 2021 | RCT | 0.53 | 0·25–1.09 | 0·081 |
Recovery Collaborative Group 2021 | RCT | 1.04 | 0.93–1.16 | 0·48 |
Sandhu et al. 2020 | NRCT | 0.13 | 0.05–0.34 | <  0.00001 |
Fixed Effect Model | 0.992 | 0.874–1.126 | --- | |
Random Effect Model | 0.40 | 0.14–1.13 | ||
Homogeneity Test X2: 18.417 P Value: 0.000 | ||||